クラミジア感染に対する免疫

Japanese Patent JP2007511227

A

The present invention provides nucleic acids, proteins and vectors for a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. trachomatis. The method employs a vector containing a nucleotide sequence encoding a Mgp002 polypeptide of a strain of Chlamydia operably linked to a promoter to effect expression of the gene product in the host. Truncated forms of the full-length Mgp002 gene are useful immunogens for protecting against disease caused by infection with Chlamydia. The invention further provides recombinant Mgp002 protein useful for protecting against disease caused by infection with Chlamydia.

Branham, Robert Sea
Lord Nikine, Ausra
Galichan, scott
Andrew, Mardin

JP2006540117A

May 10, 2007

November 19, 2004

Click for automatic bibliography generation  

SANOFI PASTEUR LIMITED

C12N15/09; A61K39/118; A61K39/39; A61P31/10; C07K14/295; C07K16/12; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; A61K39/00

JP2002517179A	2002-06-18
JP2003510050A	2003-03-18

WO2003049762A2	2003-06-19
WO2002002606A2	2002-01-10

JPN6010044758, ＧｅｎＢａｎｋ　Ａｃｅｓｓｉｏｎ　Ｎｏ．Ａ８１６８２　（１１−ＭＡＹ−２０００）（ｈｔｔｐ：／／ｗｗｗ．ｎｃｂｉ．ｎｌｍ．ｎｉｈ．ｇｏｖ／ｓｖｉｅｗｅｒ／ｖｉｅｗｅｒ．ｆｃｇｉ？ｖａｌ＝１１２８２１
JPN6010044759, ＧｅｎＢａｎｋ　Ａｃｅｓｓｉｏｎ　Ｎｏ．Ｇ７１５２５　（０４−ＦＥＢ−２０００）（ｈｔｔｐ：／／ｗｗｗ．ｎｃｂｉ．ｎｌｍ．ｎｉｈ．ｇｏｖ／ｓｖｉｅｗｅｒ／ｖｉｅｗｅｒ．ｆｃｇｉ？ｖａｌ＝７４６８９９
JPN6010044760, Ｓｃｉｅｎｃｅ，　２８２　（１９９８）　ｐ．７５４−７５９
JPN6010044761, Ｎｕｃｌｅｉｃ　Ａｃｉｄｓ　Ｒｅｓ．，　２８［６］　（２０００）　ｐ．１３９７−１４０６

Yanagita Seiji
Go Sakuma

Previous Patent: 複数の成分検出のための共振エネルギ転移アッセイ・システム

Next Patent: フィルタシガレットを製造するための設備